Literature DB >> 201353

Effect of the inhibitor of angiotensin I converting enzyme on endocrine function and renal perfusion in haemorrhagic shock.

M Yamashita, T Oyama, T Kudo.   

Abstract

The present study was undertaken to investigate the effect of inhibition of angiotensin I converting enzyme on endocrine responses and renal perfusion in haemorrhagic shock. Plasma levels of vasopressin (VP), aldosterone, and plasma renin activity (PRA), and renal cortical tissue blood flow were measured both in control dogs and in those treated with an inhibitor of angiotensin I converting enzyme (SQ20881). The drug was administered with an intention of preventing vasoconstriction induced by angiotensin II and to improve tissue perfusion. No significant differences were found in plasma levels of vasopressin, aldosterone and plasma renin activity between control and SQ20881-treated groups. Secondary elevation of blood pressure following haemorrhage was significantly delayed and reduced by the administration of the inhibitor. Decrease in renal cortical tissue blood flow was observed in the SQ20881-treated group. It is suggested that angiotension II appears to play a role in spontaneous recovery of arterial blood pressure following haemorrhage. Furthermore, angiotensin II does not seem to play an important role in the stimulation of secretion of vasopressin in response to haemorrhage. Our data failed to demonstrate any favourable effects of inhibition of angiotension I converting enzyme on renal perfusion during haemorrhagic shock in dogs.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 201353     DOI: 10.1007/bf03006712

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  18 in total

1.  Effect of inhibition of peptidase activity on distribution of intrarenal blood flow.

Authors:  M D Bailie; J A Barbour
Journal:  Am J Physiol       Date:  1975-03

2.  Intestinal vasoconstriction following diuretic-induced volume depletion: role of angiotensin and vasopressin.

Authors:  J R McNeill
Journal:  Can J Physiol Pharmacol       Date:  1974-08       Impact factor: 2.273

3.  Central action of angiotensin in stimulating ADH release.

Authors:  D Mouw; J P Bonjour; R L Malvin; A Vander
Journal:  Am J Physiol       Date:  1971-01

4.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

5.  Intestinal vasoconstriction after hemorrhage: roles of vasopressin and angiotensin.

Authors:  J R McNeill; R D Stark; C V Greenway
Journal:  Am J Physiol       Date:  1970-11

6.  Simplified radioimmunoassay for serum aldosterone utilizing increased antibody specificity.

Authors:  J K McKenzie; J A Clements
Journal:  J Clin Endocrinol Metab       Date:  1974-04       Impact factor: 5.958

7.  Plasma renin activity during pentobarbital anesthesia and graded hemorrhage in dogs.

Authors:  M D Johnson; R L Malvin
Journal:  Am J Physiol       Date:  1975-10

8.  Inhibition of angiotensin conversion and prevention of renal hypertension.

Authors:  E D Miller; A I Samuels; E Haber; A C Barger
Journal:  Am J Physiol       Date:  1975-02

9.  Renovascular resistance and noradrenaline.

Authors:  L Bomzon; C Rosendorff
Journal:  Am J Physiol       Date:  1975-12

10.  On the role of vasopressin and angiotensin in the development of irreversible haemorrhagic shock.

Authors:  M L Errington; M Rocha e Silva
Journal:  J Physiol       Date:  1974-10       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.